BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 16820616)

  • 1. Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery.
    Thielmann M; Leyh R; Massoudy P; Neuhäuser M; Aleksic I; Kamler M; Herold U; Piotrowski J; Jakob H
    Circulation; 2006 Jul; 114(1 Suppl):I441-7. PubMed ID: 16820616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Knipp S; Kottenberg-Assenmacher E; Marr A; Pizanis N; Hartmann M; Kamler M; Massoudy P; Jakob H
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):470-6. PubMed ID: 17662792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: a multicenter analysis.
    Massoudy P; Thielmann M; Lehmann N; Marr A; Kleikamp G; Maleszka A; Zittermann A; Körfer R; Radu M; Krian A; Litmathe J; Gams E; Sezer O; Scheld H; Schiller W; Welz A; Dohmen G; Autschbach R; Slottosch I; Wahlers T; Neuhäuser M; Jöckel KH; Jakob H
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):840-5. PubMed ID: 19327506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in patients with peripheral vascular disease after percutaneous coronary intervention and coronary artery bypass graft surgery.
    O'Rourke DJ; Quinton HB; Piper W; Hernandez F; Morton J; Hettleman B; Hearne M; Nugent W; O'Connor GT; Malenka DJ;
    Ann Thorac Surg; 2004 Aug; 78(2):466-70; discussion 470. PubMed ID: 15276497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased mortality and perioperative complications in patients with previous elective percutaneous coronary interventions undergoing coronary artery bypass surgery.
    Bonaros N; Hennerbichler D; Friedrich G; Kocher A; Pachinger O; Laufer G; Bonatti J
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):846-52. PubMed ID: 19327507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features.
    Brener SJ; Lytle BW; Casserly IP; Schneider JP; Topol EJ; Lauer MS
    Circulation; 2004 May; 109(19):2290-5. PubMed ID: 15117846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery bypass grafting is superior to percutaneous coronary intervention in prevention of perioperative myocardial infarctions during subsequent vascular surgery.
    Ward HB; Kelly RF; Thottapurathu L; Moritz TE; Larsen GC; Pierpont G; Santilli S; Goldman S; Krupski WC; Littooy F; Reda DJ; McFalls EO
    Ann Thorac Surg; 2006 Sep; 82(3):795-800; discussion 800-1. PubMed ID: 16928485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease.
    van Domburg RT; Lemos PA; Takkenberg JJ; Liu TK; van Herwerden LA; Arampatzis CA; Smits PC; Daemen J; Venema AC; Serruys PW; Bogers AJ
    Eur Heart J; 2005 Apr; 26(7):675-81. PubMed ID: 15637087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery.
    Pan W; Pintar T; Anton J; Lee VV; Vaughn WK; Collard CD
    Circulation; 2004 Sep; 110(11 Suppl 1):II45-9. PubMed ID: 15364837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification with cardiac troponin I in patients undergoing elective coronary artery bypass surgery.
    Thielmann M; Massoudy P; Neuhäuser M; Knipp S; Kamler M; Marggraf G; Piotrowski J; Jakob H
    Eur J Cardiothorac Surg; 2005 May; 27(5):861-9. PubMed ID: 15848327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD; Body SC; Shernan SK; Wang S; Mangano DT; ;
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):392-400. PubMed ID: 16872968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry).
    Feldman DN; Gade CL; Slotwiner AJ; Parikh M; Bergman G; Wong SC; Minutello RM;
    Am J Cardiol; 2006 Nov; 98(10):1334-9. PubMed ID: 17134624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of early coronary artery bypass graft in an unselected acute coronary syndrome patient population.
    Monteiro P;
    Circulation; 2006 Jul; 114(1 Suppl):I467-72. PubMed ID: 16820620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Previous percutaneous coronary interventions increase mortality and morbidity after coronary surgery.
    Mannacio V; Di Tommaso L; De Amicis V; Lucchetti V; Pepino P; Musumeci F; Vosa C
    Ann Thorac Surg; 2012 Jun; 93(6):1956-62. PubMed ID: 22520830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.
    Yan BP; Clark DJ; Buxton B; Ajani AE; Smith JA; Duffy SJ; Shardey GC; Skillington PD; Farouque O; Yii M; Yap CH; Andrianopoulos N; Brennan A; Dinh D; Reid CM; ;
    Heart Lung Circ; 2009 Jun; 18(3):184-90. PubMed ID: 19268632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late outcome after stenting or coronary artery bypass surgery for the treatment of multivessel disease: a single-center matched-propensity controlled cohort study.
    van Domburg RT; Takkenberg JJ; Noordzij LJ; Saia F; van Herwerden LA; Serruys PW; Bogers AJ
    Ann Thorac Surg; 2005 May; 79(5):1563-9. PubMed ID: 15854934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts.
    Upadhya B; Applegate RJ; Sane DC; Deliargyris EN; Kutcher MA; Gandhi SK; Baki TT; Call JT; Little WC
    Am J Cardiol; 2005 Aug; 96(4):515-8. PubMed ID: 16098303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.